Renavotio Inc (RIII): Congratulations to REDavotio! Winner of...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Renavotio Inc (RIII)

Reply Private New

Next 10 Prev Next

Send PM

Followers	2
Posts	623
Boards Moderated	0
Alias Born	12/07/2020

Re: None

Tuesday, 01/03/2023 4:26:42 PM

Tuesday, January 03, 2023 4:26:42 PM

Congratulations to REDavotio! Winner of worst stock of:

2021
2022
And just when you think it can't get any worse we are off to another horrific start in 2023 here at an all time low level.

There's one cheerleader left with this complete junk of a company and still is overvalued until this hits .000.

Everyone but a couple of cheerleaders saw the red flags nearly three years ago and look what has become of this complete hunk of junk.

REDavotio already strikes here in 2023!

Bearish

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent RIII News

Notification That Quarterly Report Will Be Submitted Late (nt 10-q) • Edgar (US Regulatory) • 11/15/2022 03:01:27 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 10/05/2022 11:22:59 AM
RENAVOTIO, INC. (RIII) Engages corporate accounting firm and expands its Cranberry Glove business with CONTRACTS TOTALING $177,500,000 • InvestorsHub NewsWire • 09/06/2022 09:18:10 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) • Edgar (US Regulatory) • 08/16/2022 01:47:40 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 07/19/2022 05:44:54 PM
Amended Current Report Filing (8-k/a) • Edgar (US Regulatory) • 06/29/2022 03:34:03 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/25/2022 05:42:37 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) • Edgar (US Regulatory) • 05/16/2022 02:21:09 PM
RENAVOTIO, INC. (RIII) Provides Shareholder updates • InvestorsHub NewsWire • 05/13/2022 07:38:04 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/13/2022 05:04:13 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 04/05/2022 08:57:52 PM

More RIII News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!